New US acquisition for Nestlé Health Science will strengthen Brain Health and Metabolic Health portfolios with new medical foods Dienstag, 26. Februar 2013 - 07:24

New US acquisition for Nestlé Health Science will strengthen Brain Health and Metabolic Health portfolios with new medical foods

Nestlé Health Science, a fully owned subsidiary of Nestlé, has agreed to acquire the business of Pamlab, a US-based company with an innovative portfolio of medical food products for use under medical supervision in the nutritional management of patients with mild cognitive impairment, depression and diabetic peripheral neuropathy.

The acquisition further strengthens Nestlé Health Science's capacity to deliver personalised healthcare to address chronic medical conditions through nutrition, especially in the areas of metabolic health and brain health.

Read the full story: www.nestle.com/Media/NewsAndFeatures/NHSc-acquires-Pamlab

More Nestlé news: www.nestle.com

Media enquiries Nestlé S.A. Vevey, Switzerland Tel: +41 21 924 2200 Email: mediarelations@nestle.com